You just read:

Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016

News provided by

Valeant Pharmaceuticals International, Inc.

Nov 15, 2013, 17:01 ET